Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FMEB6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,259
Award facts
- Contract value 100% obligated
- $21,259.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,259.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award, issued on December 15, 2025, with an ultimate completion date of January 7, 2026, carries no set-aside designation, indicating the contractor competed in open procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion procurement vehicle established to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical supplier within the federal pharmaceutical supply chain, with established performance across numerous delivery orders spanning oncology treatments, immunosuppressants, biologics, vaccines, and routine pharmaceuticals. The company's selection as a regional prime vendor under the $30.3 billion PPV-G GEN V acquisition strategy, combined with its consistent contract performance across multiple therapeutic categories, positions it to fulfill the specialized and recurring pharmaceutical requirements of military healthcare operations globally. This delivery order represents a routine fulfillment of the company's obligations under the broader prime vendor contract structure supporting DoD medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FMEB6?
SPE2DR26FMEB6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FMEB6 worth?
The government has obligated $21,259 on SPE2DR26FMEB6.
Is contract SPE2DR26FMEB6 an order under another contract?
Yes. SPE2DR26FMEB6 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEB6 competed?
The extent of competition for SPE2DR26FMEB6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award